Autumn 2024
Master programme
(Survey based evaluation)
Biopharmaceuticals – Quality Development and Documentation
Clinical Development and Documentation
Labelling as a Driver for Regulatory Strategy
Quality – Drug Substance and Drug Product
The EU Regulatory Environment – Procedures and Applications